I now have comprehensive information. Here is the full clinical analysis:
Clinical Diagnosis: Anticholinergic (Antimuscarinic) Toxidrome
This 3-year-old's triad of tachycardia + lethargy/altered mental status + mydriasis with normal blood sugar is classic for anticholinergic poisoning.
The Mnemonic: "Mad as a Hatter, Blind as a Bat..."
| Feature | Mnemonic | This Patient |
|---|
| Mydriasis | "Blind as a bat" | ✅ Present |
| Altered mental status / lethargy | "Mad as a hatter" | ✅ Present |
| Tachycardia | — | ✅ Present |
| Dry skin, no sweating | "Dry as a bone" | Check |
| Flushed skin | "Red as a beet" | Check |
| Hyperthermia | "Hot as hades" | Check |
| Urinary retention | "Full as a flask" | Check |
| Decreased bowel sounds | — | Check |
Note: Only 28% of patients with antimuscarinic poisoning present with all three classic features (tachycardia + dry skin/axilla + mydriasis). Most have an incomplete syndrome. — Rosen's Emergency Medicine, p. 2913
Key Distinguishing Point: Mydriasis WITH Reactive Pupils
- Anticholinergic → mydriasis with reactive (sluggish but present) pupils ✅
- Sympathomimetic → mydriasis with reactive pupils (also possible — see differential below)
- Opioids → miosis (pinpoint pupils)
- Opioid/CNS depressant → miosis + bradycardia
The reactive quality of pupils here is important. True anticholinergic mydriasis is often fixed/sluggish due to ciliary muscle blockade, but partial reactivity can still occur.
Common Causative Agents in a 3-Year-Old
| Agent | Notes |
|---|
| Antihistamines (diphenhydramine, doxylamine) | Most common accidental pediatric exposure |
| Atropine / scopolamine eye drops | Even topical application can cause systemic toxicity in toddlers |
| Datura (jimsonweed) seeds | 5–10 seeds can be toxic; classic plant toxin |
| Antipsychotics / phenothiazines | Household medication ingestion |
| Tricyclic antidepressants (TCAs) | More dangerous — causes QRS widening |
| Benztropine, trihexyphenidyl | Parkinsonian medications in household |
Diphenhydramine becomes toxic at ≥2.5 mg/kg in children, with cardiovascular/neurological toxicity at >10 mg/kg. — Rosen's Emergency Medicine, p. 2914
Differential Diagnosis
| Toxidrome | HR | Pupils | Skin | Mental Status | Key Difference |
|---|
| Anticholinergic | ↑ | Dilated | Dry, flushed | Delirium/lethargy | No diaphoresis, decreased bowel sounds |
| Sympathomimetic | ↑ | Dilated | Diaphoretic | Agitation | Diaphoresis, hypertension, hyperactive bowel |
| Serotonin syndrome | ↑ | Dilated | Diaphoretic | Agitation | Clonus, hyperreflexia, rigidity |
| Opioid | ↓ | Pinpoint | Normal | Sedation | Miosis, respiratory depression |
| Hypoglycemia | ↑ | Variable | Diaphoretic | Lethargy | Normal BG rules this out ✅ |
Management
1. Stabilization (ABC)
- Airway protection if GCS declining
- Cardiac monitoring + 12-lead ECG (rule out QRS widening — suggests TCA co-ingestion)
- IV access, continuous pulse oximetry
2. Decontamination
- Activated charcoal only if early presentation, awake, cooperative, low aspiration risk
- No role for gastric lavage or dialysis
3. Antidote: Physostigmine
Pediatric dose: 0.02 mg/kg IV (max 0.5 mg/dose) slowly over 5 min; repeat every 5 min PRN (max total dose: 2 mg) — Rosen's Emergency Medicine, p. 2914
- Onset: 5–10 min IV
- Duration: ~80 min (cholinesterase inhibition)
- Indicated for: diagnostic confirmation + treatment of antimuscarinic delirium/agitation
- Controls delirium in 79–96% of cases; superior to benzodiazepines
- Contraindications: bradycardia, AV block, active seizures, TCA cardiovascular toxicity, narrow-angle glaucoma
4. Sedation (if physostigmine unavailable or contraindicated)
- Lorazepam 0.05–0.1 mg/kg IV, or midazolam 0.05–0.1 mg/kg
- Benzodiazepines are inferior to physostigmine for delirium control and associated with longer recovery
5. Hyperthermia
- Active cooling if present; can progress to rhabdomyolysis and multi-organ failure
6. Sodium bicarbonate
- 1–2 mEq/kg IV bolus if QRS >120 ms (TCA co-ingestion with sodium channel blockade)
Workup to Order
- 12-lead ECG (QRS width — rule out TCA)
- Serum acetaminophen + salicylate levels (common co-ingestants)
- BMP, creatinine kinase (rhabdomyolysis), LFTs
- Point-of-care glucose (already done ✅)
- Consider urine toxicology screen (note: may not change acute management)
Disposition
Most children improve with supportive care. Duration of symptoms can be 18–72 hours depending on agent and dose, largely because antimuscarinic agents delay gastric emptying (prolonging their own absorption). Admit for monitoring; ICU if hyperthermia, seizures, dysrhythmia, or respiratory compromise.
Sources: Rosen's Emergency Medicine — Concepts and Clinical Practice, Chapter 140; The Harriet Lane Handbook (23rd ed.), Chapter 3; The Washington Manual of Medical Therapeutics